Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 4Mycoses 3Leukemia 3Infections 3Recurrence 2Neutropenia 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Torulopsis 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Stem Cell Transplant Complications 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumours 1Sezary Syndrome 1Seminoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Voriconazole 3Itraconazole 2Amphotericin B 2posaconazole 1liposomal amphotericin B 1isavuconazole 1Solutions 1Fluconazole 1Caspofungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Invasive Fungal Infections × Fluconazole × Clear all
NCT01307579 2021-03-30

Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia

Children's Oncology Group

Phase 3 Completed
517 enrolled 14 charts
Other hematologic neoplasm

Invasive Fungal Infections, Leukemia, Leukemia, Monocytic, Acute, Mycoses, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡